ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2806 • 2014 ACR/ARHP Annual Meeting

    Characteristic Phenotype of Peripheral Blood Lymphocytes in Patients with IgG4-Related Disease, Comparing to Primary Sjögren Syndrome and Healthy Controls

    Shintaro Hirata, Shingo Nakayamada, Satoshi Kubo, Maiko Yoshikawa, Naoki Yunoue, Kazuhisa Nakano, Kunihiro Yamaoka, Kazuyoshi Saito and Yoshiya Tanaka, The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

    Background/Purpose : IgG4-related disease (IgG4-RD) is a systemic disease that is characterized by the infiltration of IgG4-positive plasma cells and T cells into various organs.…
  • Abstract Number: 2807 • 2014 ACR/ARHP Annual Meeting

    Comparison of Outcomes in Septic Arthritis Caused By MRSA and MSSA

    Deepa Panikkath1, Sian Yik Lim2, Swetha Gadwala3, Ragesh Panikkath3 and Kenneth Nugent4, 1INTERNAL MEDICINE, Texas Tech University of Health Sciences, Lubbock, LUBBOCK, TX, 2Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 3Internal Medicine, Texas Tech University of Health Sciences, Lubbock, TX, 43601, Texas Tech University Health Sciences Center, Lubbock, TX

    Background/Purpose:  Staphylococcus aureus is the most common cause of adult septic arthritis and the incidence of methicillin-resistant Staphylococcus aureus (MRSA) infections continues to rise. There…
  • Abstract Number: 2809 • 2014 ACR/ARHP Annual Meeting

    Human Papilloma Virus and Chlamydia Trachomatis Infections in Rheumatoid Arthitis Under Anti-TNF Therapy

    Mariana G Waisberg1, Ana C.M. Ribeiro2, Wellington M. Candido1, Poliana B. Medeiros1, Cezar N. Matsuzaki3, Mariana C. Beldi1, Maricy Tacla1, Helio H. Caiaffa-Filho4, Eloisa Bonfá1 and Clovis A Silva5, 1Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 2Rheumatology Division, University of Sao Paulo, Sao Paulo, Brazil, 3Gynecology Department, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 4Central Laboratory Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 5Pediatric Rheumatology Unit, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Cervical human papillomavirus (HPV) infection has been observed in 28% of rheumatoid arthritis (RA) patients in a cross-sectional study with no available data regarding…
  • Abstract Number: 2810 • 2014 ACR/ARHP Annual Meeting

    Reduced Mortality Risk in Rheumatoid Arthritis: Findings from Two UK Inception Cohorts

    Sam Norton1, Elena Nikiphorou2, Lewis Carpenter3, David Walsh4,5, Patrick Kiely6, Josh Dixey7 and Adam Young2,8, 1Institute of Psychiatry, King's College London, London, United Kingdom, 2School of Life & Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, 3Centre for Lifespan & Chronic Illness Research, University of Hertfordshire, Hatfield, United Kingdom, 4Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, United Kingdom, 5Rheumatology, Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, United Kingdom, 6Rheumatology Dept, St. Georges Healthcare NHS Trust, London, United Kingdom, 7Rheumatology, New Cross Hospital, Wolverhampton, United Kingdom, 8Rheumatology, ERAS, St Albans City Hospital, St Albans, United Kingdom

    Background/Purpose Rheumatoid arthritis (RA) is associated with a 20 to 30% increased risk of mortality from all-causes compared to the general population. The aim of…
  • Abstract Number: 2811 • 2014 ACR/ARHP Annual Meeting

    Improvements in Rheumatoid Arthritis Related Fatigue Are Driven By Reductions in Pain, Not Disease Activity – Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

    Katie L Druce1, Gareth T Jones2, Gary J. Macfarlane1 and Neil Basu1, 1Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Musculoskeletal Research Collaboration (Epidemiology Group),, University of Aberdeen, Aberdeen, United Kingdom

    Background/Purpose: Rheumatoid Arthritis (RA) patients commonly report reductions in fatigue after commencing Anti-TNF therapy. The mechanisms behind such reductions have not been determined, although it…
  • Abstract Number: 2812 • 2014 ACR/ARHP Annual Meeting

    Is Rheumatoid Arthritis the Same Disease in Women and Men?- Joint Damage in Patients with EARLY Rheumatoid Arthritis at 10 YEARS after Diagnosis

    Juha Asikainen1, Kalevi Kaarela2, Heidi Mäkinen3, Hannu Kautiainen4, Pekka Hannonen5, Tuomas Rannio6 and Tuulikki Sokka7, 1Jyvaskyla Central Hospital, Jyväskylä, Finland, 2Jyväskylä Central Hospital, Jyväskylä, Finland, 3Tampere University Hospital, Tampere, Finland, 4Medcare Oy, Äänekoski, Finland, 5Jyväskylä Central Hospital, Jyvaskyla, Finland, 6Kuopio University Hospital, Kuopio, Finland, 7Jyvaskyla Central Hospital, Jyvaskyla, Finland

    Background/Purpose: Rheumatoid arthritis (RA) is suggested to be a more severe disease in women than in men as disease activity appears higher in women, and…
  • Abstract Number: 2813 • 2014 ACR/ARHP Annual Meeting

    Correlation of Morning Stiffness with Measures of Higher Disease Activity in a Large US Registry Population of Rheumatoid Arthritis Patients

    Vibeke Strand1, Robert J. Holt2, Katherine C. Saunders3, Jeffery D. Kent4, Ping Xu5, Amy Y. Grahn4, Marc Mason3 and Carol J. Etzel6,7, 1Stanford University, Palo Alto, CA, 2University of Illinois - Chicago, Chicago, IL, 3Corrona, LLC., Southborough, MA, 4Horizon Pharma, Inc., Deerfield, IL, 5Axio Research LLC, Seattle, WA, 6PO Box 786, Corrona, LLC., Southborough, MA, 7Department of Epidemiology, UT MD Anderson, Houston, TX

    Background/Purpose : Morning stiffness may not be specifically queried by rheumatologists in the course of their regular interactions with rheumatoid arthritis (RA) patients.  This analysis…
  • Abstract Number: 2814 • 2014 ACR/ARHP Annual Meeting

    Time-to-Remission, Time-to-Relapse and Disease Severity at the Time of Relapse in RA- Results from the Ontario Best Practices Research Initiative (OBRI)

    Bindee Kuriya1, Xiuying Li2, Binu Jacob2, Pooneh Akhavan3, Jessica Widdifield4, Mark Tatangelo5, Janet E. Pope6, Edward Keystone7 and Claire Bombardier8, 1Rheumatology, University of Toronto, Toronto, ON, Canada, 2University Health Network, Toronto General Research Institute, Toronto, ON, Canada, 3Medicine, Early Rheumatoid Arthritis Program, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 4200 Elizabeth St, University of Toronto, Toronto, ON, Canada, 5Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada, 6Medicine, Western University, London, ON, Canada, 7Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 8Rheumatology, Institute for Work & Health, Toronto, ON, Canada

    Background/Purpose: Clinical remission in RA is the desired goal, however the ability to sustain remission and the timing and severity of relapse is not well…
  • Abstract Number: 2774 • 2014 ACR/ARHP Annual Meeting

    Why Leg Ulcers Do Not Heal? a Prospective Study Showing High Proportion of Small Vessel Vasculitis

    Vinod Ravindran1, Sunil Rajendran2 and Ranjish Vijayan2, 1National Hospital, Kozhikode, Kerala, India, 2PVS Hospital, Kozhikode, India

    Background/Purpose: Non healing cutaneous ulcers of lower limbs can have several different aetiologies [1]. It is likely that the patients with such ulcers would be…
  • Abstract Number: 2775 • 2014 ACR/ARHP Annual Meeting

    Cutaneous Vasculitis Associated with Severe Bacterial Infections. Study of 27 Patients from a Series of 766 Cutaneous Vasculitis

    Leyre Riancho-Zarrabeitia1, Javier Loricera1, Ricardo Blanco1, Jose L. Hernández2, Vanesa Calvo-Río1, Francisco Ortiz Sanjuan1, Cristina Mata-Arnaiz1, Javier Rueda-Gotor1, Lino Álvarez3, Carmen Gonzalez-Vela4, Marcos A. González-López5, Susana Armesto5, Trinitario Pina Murcia6, Montserrat Santos-Gómez1 and Miguel A. González-Gay1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 2Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 3Pediatrics, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 4Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 5Dermatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 6Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain

    Background/Purpose: To assess the clinical spectrum of severe bacterial infections presenting as cutaneous vasculitis (CV) in a defined population. Methods: Unselected series of 766 patients…
  • Abstract Number: 2776 • 2014 ACR/ARHP Annual Meeting

    Drug-Associated Cutaneous Vasculitis: Study of 239 Patients from a Single Referral Center

    Montserrat Santos-Gómez1, Francisco Ortiz Sanjuan1, Ricardo Blanco1, Jose L. Hernández2, Vanesa Calvo-Río1, Javier Loricera1, Carmen Gonzalez-Vela3, Trinitario Pina Murcia4, Hector Fernandez-Llaca5, Susana Armesto5, Victor Martínez-Taboada1, Javier Rueda-Gotor1, Leyre Riancho-Zarrabeitia1 and Miguel A. González-Gay1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 2Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 3Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 4Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, 5Dermatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain

    Background/Purpose The 2012 International Chapel Hill Consensus Conference on the Nomenclature of Vasculitides defined drug-associated immune complex vasculitis as a distinct entity included within the…
  • Abstract Number: 2777 • 2014 ACR/ARHP Annual Meeting

    Clinical-Biological Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data from a French Nationwide Study on 57 Patients

    Marie Jachiet1, Alain Le Quellec2, Alban Deroux3, Pascal Godmer4, Mikael Ebbo5, Leonardo Astudillo6, Beatrice Flageul7, Nicolas Dupin8, Selim Aractingi1, Loïc Guillevin for the French Vasculitis Study Group9, Luc Mouthon9 and Benjamin Terrier10, 1Dermatology, Cochin Hospital, Paris, France, 2Division of internal Medicine, Hôpital Saint-Eloi, Centre Hospitalier Universitaire de Montpellier, Montpellier, Montpellier, France, 3Internal Medicine, CHU Grenoble, Grenoble, France, 4Department of Internal Medicine, Centre Hospitalier Bretagne Atlantique de Vannes, Vannes, France, 5Internal Medicine, CHU, Marseille, France, 6Internal Medicine, CHU, Toulouse, France, 7Dermatology, Saint Louis, Paris, France, 8Service de Dermatologie, Hôpital Cochin, AP-HP, Paris, France, 9National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 10National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France

    Background/Purpose Hypocomplementemic urticarial vasculitis (HUV), an uncommon vasculitis of unknown etiology, is rarely reported. It is also called anti-C1q vasculitis in the 2012 revised International…
  • Abstract Number: 2778 • 2014 ACR/ARHP Annual Meeting

    Non-Systemic Vasculitic Neuropathy: Presentation, Therapeutic Management and Outcome

    Benjamin Terrier1, Fleur Cohen2, Aude Rigolet3, Jean-Emmanuel Kahn4, Alice Berezne5, Olivier Benveniste6, Alain Créange7, Thierry Maisonobe8, Zahir Amoura9, Luc Mouthon10 and Loïc Guillevin for the French Vasculitis Study Group10, 1National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 2Internal Medicine, Pitié-Salpétrière, Paris, France, 3Department: inflammation, immunopathology and biotherapy (DHU i2B), Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, Paris, France, 4Internal Medicine, Foch Hospital, Suresnes, France, 5Paris Descartes University, Internal Medicine department, Cochin Hospital, Paris, France, 6UMR 974, Sorbonne Universités, University Pierre et Marie-Curie-Paris 6, INSERM, Paris, France, 7Neurology, Henri Mondor, Créteil, France, 8Neuropathology, Pitie-Salpetriere Hospital, Paris, France, 9Internal medicine 2, French National Reference Center for Systemic Lupus and Antiphospholipid Syndrome, Pitié-Salpêtrière Hospital (AP-HP), Paris, France, 10National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France

    Background/Purpose Non-systemic vasculitic neuropathy (NSVN) is a small-to-medium–sized vessel vasculitis limited to the peripheral nervous system. It can be considered a single-organ vasculitis, as recently…
  • Abstract Number: 2779 • 2014 ACR/ARHP Annual Meeting

    Systemic Inflammatory and Autoimmune Manifestations Associated with Myelodysplastic Syndrome: A French Multicenter Retrospective Study

    Arsene Mekinian1, Eric Grignano1, Thorsten Braun2, Olivier Decaux3, Eric Liozon4, Nathalie Costedoat-Chalumeau5, Jean Emmanuel Kahn6, Mohamed Hamidou7, Geraldine Falgarone8, Olivier Lortholary9, Sophie Park10, Zahir Amoura11, A. Mathian12, Bruno Gombert13, Christian Rose14, Xavier Puechal15, David Launay16, Guillaume Denis17, Bertrand Lioger18, Anne Laure Buchdaul19, Sophie georgin Lavialle20, Francois Montestruc21, Mohammed Omouri22, Julien Rossignol23, Jean Marc Ziza24, Pascal Cathebras25, Serge Madaule26, Benoit de Wazières27, Nathalie Morel15, Sebastien Trouillet28, Loic Raffray29, Yoland Schoindre30, Eric Toussirot31, jean Charles Piette32, Claude Gardin2, Lionel Ades33, Pierre Fenaux33 and Olivier Fain34, 1Internal Medicine, DHUi2B Saint Antoine Hospital, paris, France, 2Haematology department Avicenne Hospital, bobigny, France, 3Department of Internal Medicine, Rennes University Hospital, Rennes, France, 4INTERNAL MEDICINE, DIJON, France, 5Internal Medicine, Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 6Internal medicine Hopital Foch, PARIS, France, 7CHU Hôtel Dieu, Nantes, Nantes, France, 8Rheumatology department Avicenne Hospital INSERM 1125, bobigny, France, 9Service de maladies infectieuses, Hôpital Necker-Enfants malades, AP-HP, Paris, France, 10Haematology Department, Grenoble University Hospital, grenoble, France, 11Internal medicine 2, French National Reference Center for Systemic Lupus and Antiphospholipid Syndrome, Pitié-Salpêtrière Hospital (AP-HP), Paris, France, 12Internal Medecine Department, Pitie-Salpetriere Hospital, Paris, France, 13Internal Medicine, La Rochelle hospital, La Rochelle, France, 14haematology, lille, France, 15Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 16Service de médecine interne, Centre National de Référence de la Sclérodermie Systémique, Hôpital Claude Huriez, CHRU Lille, Lille, France, 17Internal Medicine, Rochefoucault hospital, Rochefoucault, France, 18INTERNAL MEDICINE, tours, France, 19Internal Medicine, Douai hospital, Douai, France, 20Internal Medicine Department Tenon Hospital, paris, France, 21exystat, PARis, France, 22Rheumatology Department Romilly Hospital, romilly, France, 23haematology, paris, France, 24Hopital Croix-Saint-Simon, Paris Cedex 20, France, 25Internal Medicine, University Hospital St Etienne, St Etienne, France, 26Medecine interne, Chg, Albi, France, 27Department of Internal Medicine and Gerontology, Hôpital Universitaire Carémeau, Nîmes, France, Nimes, France, 28INTERNAL MEDICINE, aurillac, France, 29INTERNAL MEDICINE, bordeaux, France, 30DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, PARIS, France, 31Clinical Investigation Centre Biotheraoy CIC 1431, Rheumatology Department, Univesity Hospital, besancon, France, 32INTERNAL MEDICINE, PARIS, France, 33Haematology department Saint Louis Hospital, paris, France, 34Hôpital Saint Antoine, DHU i2B, Service de Médecine Interne, paris, France

    Background/Purpose: To describe characteristics, treatment and outcome of patients with systemic inflammatory or autoimmune diseases (SAID) and myelodysplastic syndrome (MDS).Methods: For this retrospective study, a…
  • Abstract Number: 2780 • 2014 ACR/ARHP Annual Meeting

    Effectiveness of a Sequential Treatment with Intravenous Prostaglandins Followed By Bosentan in Patients with Buerger Disease and Severe Ischemic Lesions: A Case Series

    Helena Borrell1, Javier Narváez2, Milagros Ricse1, Eulalia Armengol1, Andrea Zacarias1, Sergi Heredia1, Carmen Gomez Vaquero1 and Joan Miquel Nolla1, 1Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 2Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain

    Background/Purpose: Buerger disease or tromboangitis obliterans (TAO) is a distinct form of systemic vasculitis of unknown etiology though strongly linked to cigarette smoking. It affects…
  • « Previous Page
  • 1
  • …
  • 1864
  • 1865
  • 1866
  • 1867
  • 1868
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology